A family history of CM poses the highest risk for the development of melanoma [4,5] and germline mutations in some high-penetrance CM susceptibility genes have been described, namely in CDKN2A, CDK4, MITF, TERT, BAP1, and POT1 [6,7]. This evidence concerns the gene CDK4 and cutaneous mastocytosis.